|
Patent landscape, scope, and claims: |
United States Patent 3,883,545: Scope, Claims, and Landscape
What does US 3,883,545 cover?
US Patent 3,883,545 is listed in the USPTO patent records as a “drug” patent and is assigned publication/issue details consistent with a late-1970s filing and grant window. The record identifies the application as a United States patent for a drug product and/or drug composition and provides the standard claim set typical of that era, including composition claims and method-of-use or method-of-manufacture claims, depending on claim numbering in the granted patent.
What is the claim scope in US 3,883,545?
The patent’s claims define protected subject matter in three common buckets for that period:
- Composition claims: cover drug active ingredient(s) and specific formulations, often tied to defined excipients, salts, hydrates, or concentration ranges.
- Method claims: cover therapeutic use, treatment regimens, or process steps for making the drug.
- Optional dependent claims: narrow composition and method claims using additional limitations such as dosage form, particle size ranges, stability conditions, or specific treatment parameters.
The effective enforceable scope is determined by:
- Independent claims (broadest coverage)
- Claim dependencies (how narrow elements constrain broader independent claims)
- Definitions in the specification that limit what a claim term means
What do the independent claims protect?
Independent claims typically set the outer boundary by reciting:
- A specific chemical entity (or salt/derivative) that is the active drug
- A defined formulation (e.g., a pharmaceutical composition) that recites measurable parameters
- A therapeutic indication or treatment method, if method claims are present
- A set of exclusionary or limiting features, such as:
- specified concentration or ratio
- presence/absence of certain excipients
- specific administration route (if recited)
- specific manufacturing steps or process parameters (if recited)
How broad are the dependent claims?
Dependent claims in US drug patents from this period typically:
- Narrow independent composition claims by locking in:
- exact amounts (or narrower ranges)
- particular salt forms
- specific dosage forms (tablet, capsule, liquid)
- stability or storage conditions if tied to formulation limits
- Narrow method claims by specifying:
- patient population parameters (if any were recited)
- dosing intervals
- treatment duration
From a landscape perspective, the dependent claims are critical because they often define:
- “Design-around” thresholds: what changes would avoid the specific limitation set
- What a generic must prove not to infringe, if the generic copies the formulation and method steps
Where does US 3,883,545 sit in the patent landscape?
Without the claim text and bibliographic details (inventor, assignee, drug name, and independent claim language), the most reliable landscape mapping cannot be completed in a way that is decision-grade. US drug patents create multi-layered boundaries around:
- Active ingredient (compound or salt scope)
- Formulation (excipients, carriers, dosage forms)
- Use (therapeutic indications)
- Process (manufacturing method)
A full landscape for US 3,883,545 requires:
- its drug identity
- the assertable independent claim elements
- its priority dates
- its assignee and prosecution history
- the relevant family members (continuations, divisionals, counterparts)
What does this mean for freedom-to-operate (FTO)?
For drug products, infringement risk is driven by whether a commercial product:
- uses the same active ingredient form (including salt/hydrate/derivative)
- matches the claimed formulation limitations
- follows the claimed method-of-use
- matches any claimed process limitations tied to manufacture
For investors, valuation sensitivity typically concentrates on whether:
- later patents in the same family expand claim scope around reformulation or additional indications
- competitors hold blocking position on the same active ingredient family but with different claim types (compound vs formulation vs use)
Practical landscape construction (what to map around this patent)
A robust analysis would ordinarily build a map across:
- Same-family filings (continuations/divisionals) that may add narrower formulation or use claims
- US and WO counterparts to establish priority and claim interpretation anchor points
- Competing patents around:
- alternative salts/hydrates
- alternative dosage forms
- alternative formulations with similar actives
- alternative treatment regimens
- Generic entry risk drivers:
- granted composition claims vs use claims
- whether later expiration dates attach to dependent claim scope
Key Takeaways
- US 3,883,545’s enforceable scope depends on its independent claim elements and the narrowing effect of dependent claims.
- The patent landscape for a drug patent is determined by whether claims cover composition, method-of-use, process, or combinations.
- Decision-grade landscape mapping requires the drug identity and the actual claim text to determine design-arounds and competing claim blocks.
FAQs
-
Are drug patents like US 3,883,545 enforceable against generics?
Enforceability depends on whether the generic product practices the claimed composition and/or method limits, including salt/formulation specifics.
-
Do dependent claims matter more than independent claims for FTO?
Dependent claims can be decisive where they include formulation or dosing parameters that constrain design-around options.
-
How do formulation claims affect market entry?
A generic may be blocked even if it uses the same active ingredient, when the generic’s formulation matches claimed excipients, ratios, or dosage form limitations.
-
Do method-of-use claims create different infringement risk than composition claims?
Yes. Method-of-use can require proving use of a claimed therapeutic regimen or dosing steps, which can differ by label and physician prescribing patterns.
-
What is the fastest way to understand the patent’s practical scope?
Identify the independent claim elements and any specification definitions that control claim terms, then match those limitations to commercial product attributes and label-based use.
References
[1] USPTO Patent Full-Text and Image Database. “US Patent 3,883,545.” United States Patent and Trademark Office. https://patents.google.com/patent/US3883545
[2] Google Patents. “US 3,883,545.” https://patents.google.com/patent/US3883545
More… ↓
⤷ Start Trial
|
